See you in Toronto for WSC 2023!

04 Oct 2023

See you in Toronto for WSC 2023!

The eagerly anticipated WSC 2023 is just several days away, and we're thrilled to welcome you at this remarkable scientific congress in Canada. It promises to be an exceptional gathering of diverse and prominent stroke experts who will be shaping the future of stroke care.

If you haven't already registered, there's still time to secure your spot, whether you prefer to attend in person or virtually.

Active participation in the sessions and engaging in discussions at WSC 2023 will not only deepen your understanding of stroke prevention but also offer the opportunity to earn up to 18 CME credits.

Don't miss the chance to stay at the forefront of advancements in stroke care by being a part of WSC 2023!

Groundbreaking clinical trials at the core of the program

Be sure not to overlook the revolutionary clinical trials in stroke and cerebrovascular diseases showcased at WSC 2023. Discover a glimpse of the trials scheduled for presentation in Toronto:

Prof. Stuart Connolly (Canada)

Randomized trial of andexanet alfa versus usual care in patients with acute intracranial hemorrhage while on an oral factor Xa inhibitor: ANNEXa-I

Prof. Dr. Götz Thomalla (Germany)

Results of the randomized controlled trial to test efficacy and safety of thrombectomy in stroke with extended lesion and extended time window: TENSION

Prof. Keith Muir (UK)

Tenecteplase versus alteplase for acute stroke within 4.5H of onset: The second alteplase-tenecteplase trial evaluation for stroke thrombolysis (ATTEST-2)

Dr. Sheila Martins, WSO president (Brazil)

Polypill and Riskometer To Prevent Stroke And Cognitive Impairment In Primary Health Care – PROMOTE STUDY

Prof. Yongjun Wang (China)

Colchicine In High-Risk Patients With Acute Minor-To-Moderate Ischemic Stroke Or Transient Ischemic Attack (Chance-3): A Multicenter Randomized Placebo-Controlled Trial

Dr. James Christenson (USA)

A Randomized Controlled Trial Of Nerinetide Initiated By Paramedics In The Field For Acute Stroke Within Three Hours Of Symptom Onset (Frontier Trial)

Dive into a world of invaluable insights shared by leading stroke experts, gain firsthand knowledge about cutting-edge therapies, and become part of the vibrant community actively shaping the future of stroke care.